Compare
Bioharvest Sciences Inc. vs Verrica Pharmaceuticals Inc. vs Earth Science Tech, Inc. vs Lftd Partners Inc.
| Latest fiscal year | Bioharvest Sciences Inc. BHST | Verrica Pharmaceuticals Inc. VRCA | Earth Science Tech, Inc. ETST | Lftd Partners Inc. LIFD |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-03-31 | 2025-12-31 |
| Revenue | $34.51M | $35.58M | $35.70M | $36.92M |
| Revenue growth (YoY) | +37.0% | +370.2% | +7.8% | -1.1% |
| Gross margin | 59.3% (computed) | n/a | 71.4% | 34.2% |
| Operating margin | -16.2% | -34.2% | n/a | 2.5% |
| Net margin | -32.3% | -50.3% | 10.2% | -67.3% |
| Net income | -$11.13M | -$17.89M | $3.63M | -$24.86M |
| EPS (Diluted) | n/a | -$1.68 | $0.012 | -$1.68 |
| Operating cash flow | -$7.23M | -$17.63M | $1.94M | $1.32M |
| Free cash flow | -$9.58M | -$17.63M | $1.18M | $1.20M |
| Cash & equivalents | $23.02M | $30.15M | $796.8K | $1.77M |
| Total assets | n/a | $47.13M | $8.97M | $19.27M |
| Total liabilities | n/a | $22.39M | $1.93M | $6.64M |
| Shareholders' equity | $25.45M | $24.74M | $7.01M | $12.63M |
| Return on year-end equity | -43.8% | -72.3% | 51.8% | -196.8% |
| Shares outstanding | n/a | 17.18M | 291.32M | 14.82M |
Revenue, most recent five fiscal years
| Fiscal year | Bioharvest Sciences Inc. | Verrica Pharmaceuticals Inc. | Earth Science Tech, Inc. | Lftd Partners Inc. |
|---|---|---|---|---|
| Latest | $34.51M Ended 2025-12-31 | $35.58M Ended 2025-12-31 | $35.70M Ended 2026-03-31 | $36.92M Ended 2025-12-31 |
| 1 year earlier | $25.19M Ended 2024-12-31 | $7.57M Ended 2024-12-31 | $33.12M Ended 2025-03-31 | $37.33M Ended 2024-12-31 |
| 2 years earlier | $12.67M Ended 2023-12-31 | $5.12M Ended 2023-12-31 | $11.95M Ended 2024-03-31 | $51.61M Ended 2023-12-31 |
| 3 years earlier | n/a | $9.03M Ended 2022-12-31 | $48.5K Ended 2023-03-31 | $57.42M Ended 2022-12-31 |
| 4 years earlier | n/a | $12.00M Ended 2021-12-31 | $14.1K Ended 2022-03-31 | $31.66M Ended 2021-12-31 |